Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following properties of Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, & tolerability of AVP-786 (deudextromethorphan hydrobromide/quinidine sulfate) for agitation treatment in patients w/ dementia of the Alzheimer's type

PropertyValue
label Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, & tolerability of AVP-786 (deudextromethorphan hydrobromide/quinidine sulfate) for agitation treatment in patients w/ dementia of the Alzheimer's type

Search Criteria
  • agitation
  • dementia